Coagulopathy: the Most Important Thing We Still Don't Know About Snakebite

Overview

Journal West J Emerg Med

Specialty Emergency Medicine

Date 2012 Mar 31

PMID 22461926

Authors

Eric J Lavonas

Affiliations

Soon will be listed here.

References

Moriarity R, Dryer S, Replogle W, Summers R . The role for coagulation markers in mild snakebite envenomations. West J Emerg Med. 2012; 13(1):68-74. PMC: 3298204. DOI: 10.5811/westjem.2011.6.6729. View

Lavonas E, Kokko J, Schaeffer T, Mlynarchek S, Bogdan G, Dart R . Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite. Ann Emerg Med. 2010; 57(2):128-137.e3. DOI: 10.1016/j.annemergmed.2010.06.550. View

Dart R, Seifert S, Boyer L, Clark R, Hall E, McKinney P . A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001; 161(16):2030-6. DOI: 10.1001/archinte.161.16.2030. View

Ruha A, Curry S, Albrecht C, Riley B, Pizon A . Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom. Toxicon. 2010; 57(1):53-9. DOI: 10.1016/j.toxicon.2010.09.014. View

ONeil M, Mack K, Gilchrist J, Wozniak E . Snakebite injuries treated in United States emergency departments, 2001-2004. Wilderness Environ Med. 2007; 18(4):281-7. DOI: 10.1580/06-WEME-OR-080R1.1. View

Lavonas E, Ruha A, Banner W, Bebarta V, Bernstein J, Bush S . Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011; 11:2. PMC: 3042971. DOI: 10.1186/1471-227X-11-2. View

Ruha A, Curry S, Beuhler M, Katz K, Brooks D, Graeme K . Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med. 2002; 39(6):609-15. DOI: 10.1067/mem.2002.123698. View

Kitchens C, Eskin T . Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome. J Med Toxicol. 2008; 4(3):180-3. PMC: 3550043. DOI: 10.1007/BF03161198. View

Dart R, Seifert S, Carroll L, Clark R, Hall E, Curry S . Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997; 30(1):33-9. DOI: 10.1016/s0196-0644(97)70107-0. View

10.

OBrien N, DeMott M, Suchard J, Clark R, Peterson B . Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation. Pediatr Emerg Care. 2009; 25(7):457-9. DOI: 10.1097/PEC.0b013e3181ab7871. View

11.

Boyer L, Seifert S, Clark R, McNALLY J, Williams S, Nordt S . Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med. 1999; 159(7):706-10. DOI: 10.1001/archinte.159.7.706. View

12.

Fazelat J, Teperman S, Touger M . Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine). Clin Toxicol (Phila). 2008; 46(9):823-6. DOI: 10.1080/15563650701753849. View

13.

Lavonas E, Gerardo C, OMalley G, Arnold T, Bush S, Banner Jr W . Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med. 2004; 43(2):200-6. DOI: 10.1016/j.annemergmed.2003.08.009. View